Strix Group Plc Successful Placing to raise £190 million

STRIX GROUP PLC

Strix Group Plc, the designer, manufacturer and supplier of kettle safety controls and other complementary water temperature management components, is pleased to announce the successful pricing of its initial public offering (the “IPO”) and the placing (the “Placing”) of 190 million ordinary shares at 100 pence per share (the “Placing Price”) to raise £190 million. Trading on the AIM Market of the London Stock Exchange will commence on 8 August 2017 (“Admission”).

Highlights

· The Placing has raised £190 million via the placing of 190 million new ordinary shares at a placing price of 100 pence per share.

· The Company’s market capitalisation on Admission, based on the Placing Price, is expected to be £190 million.

· The Placing saw strong demand from a range of institutional investors.

· It is expected that dealings will commence on AIM at 8.00am on 8 August 2017. The ordinary shares will trade under the ticker “KETL” and the ISIN number is: IM00BF0FMG91.

Zeus Capital is acting as Nominated Adviser and Sole Broker to the Company.

Mark Bartlett, CEO of Strix Group Plc, commented:

I am delighted to announce that our initial public offering has been successful. We look forward to joining AIM on the 8th August and I would like to welcome our new shareholders to the Company.

The Placing and Admission to AIM will position the Company appropriately for the next stage of its development, in particular enabling us to invest in our new product development capabilities to the benefit of our valued customers. We look forward to being a public company and further growth across our business in existing and new markets.

To read the full RNS please click here

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:

Latest Company News

Genflow Biosciences reports early findings from SIRT6 gene therapy study

Genflow Biosciences reports early findings from its SIRT6 gene therapy study in older dogs, with further monitoring planned over...

Ilika CEO to discuss battery gigafactory development at Barcelona industry forum

Ilika CEO Graeme Purdy is set to speak at the December 2026 Barcelona battery gigafactory forum, bringing the company's...

Investors demand clear returns as AI spending comes under scrutiny

Investors are demanding clearer returns from AI spending as technology shares face pressure, with corporate earnings, data centre investment...

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

itim Group targets retail AI market with new platform launch

ITIM Group is targeting the retail AI market with itimAIQ, a new platform designed to automate operations, improve efficiency...

Drax sets date for 2026 Capital Markets Day and trading update

Drax Group will host its Capital Markets Day on 23 November 2026, providing investors and analysts with a management...

    Search